NMN
Also known as: Nicotinamide mononucleotide, β-NMN
Nicotinamide riboside monophosphate; converted to NAD+ via NMNAT enzymes; supports mitochondrial energy, DNA repair, and sirtuin-mediated longevity pathways.
Last reviewed: 2026-06-23 · 1 indexed study
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Nicotinamide mononucleotide (NMN) is a direct NAD+ precursor that raises systemic NAD+ levels, supporting cellular energy, sirtuin activity, and metabolic health.
Mechanism & Function
Mechanism of Action
Raises tissue NAD+ levels that decline with age, supporting sirtuin function, mitochondrial biogenesis, and DNA repair.
Physiological Role
Used in longevity stacks; RCT evidence shows insulin sensitivity and aerobic capacity improvements in older adults; trained-athlete data emerging.
Primary Pathways
Performance / Health Relevance
Human RCTs in middle-aged and older adults show NAD+ elevation and modest physiological benefits; long-term outcome data pending.
Evidence Review
No meta-analyses or systematic reviews indexed for this ingredient yet.
Dimensions marked N/A have no indexed evidence of that class. They are shown as unavailable rather than scored.
Compare Vitamin B3 (Niacin) Forms
Full comparison5 vitamin b3 (niacin) forms are indexed. Bioavailability, clinical evidence, and best-use cases differ meaningfully between them.
| Form | Evidence |
|---|---|
NMNThis page Oral NMN raises plasma NAD+; sublingual delivery may improve bypass of gut conversion. | 54/100 |
| Vitamin B3 (Niacin) Both nicotinic acid and nicotinamide are well absorbed orally. Nicotinic acid has varying pharmacokinetic profiles depending on the formulation (immediate-release vs. sustained-release). | 80/100 |
| Vitamin B3 (Niacinamide) Highly bioavailable orally, with absorption rates typically exceeding 90%. | 65/100 |
| Nicotinamide Riboside Oral NR increases circulating NAD+ and, in at least one trial, brain NAD+; magnitude of change is variable between individuals. | 61/100 |
| Nicotinamide Mononucleotide Rapidly absorbed and converted to NAD+ within 30 minutes. Some degradation by CD73 ectoenzyme in the GI tract — sublingual delivery may improve yield. | 50/100 |
Practical Use & Dosage
- Minimum Effective Dose
- 125 mg/day
- Optimal Range
- 250–500 mg/day
- Upper / Caution Level
- ~1000 mg/day
- Timing
- Morning, with or without food
- Best Format
- Capsule, sublingual
- Bioavailability
- Oral NMN raises plasma NAD+; sublingual delivery may improve bypass of gut conversion.
- Absorption Considerations
- Converted to nicotinamide riboside in gut, then to NMN intracellularly; mechanism debated.
Safety & Interactions
Side Effects
- •Generally well tolerated
Contraindications
- Active cancer (theoretical NAD+ tumour support)
Drug Interactions
- •None established
Who Should Avoid
- •Pregnancy (limited data)
Monitoring
None routine.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is NMN typically used or indicated?
NMN is most commonly used for: NAD+ precursor, Longevity, Metabolic health, Cellular energy. Used in longevity stacks; RCT evidence shows insulin sensitivity and aerobic capacity improvements in older adults; trained-athlete data emerging.
How does NMN work?
Raises tissue NAD+ levels that decline with age, supporting sirtuin function, mitochondrial biogenesis, and DNA repair.
What is the recommended dose of NMN?
The optimal range is 250–500 mg/day. with a minimum effective dose of 125 mg/day. Best taken: Morning, with or without food. Upper / caution level: ~1000 mg/day.
What are the side effects of NMN?
Reported side effects include: Generally well tolerated. Monitoring: None routine.
Does NMN interact with medications?
Known or theoretical interactions: None established. Always check with a clinician before combining with prescription medication.
Who should avoid NMN?
NMN is generally not recommended for: Pregnancy (limited data); and Active cancer (theoretical NAD+ tumour support).
How strong is the evidence for NMN?
Evidence level: Limited (overall score 54/100), based on 1 indexed study on SuppIndex.
Research & References (1)
NMN supplementation in middle-aged adults: RCT
Dose-dependent NAD+ elevation and improved 6-minute walk test.
Related Ingredients
Other top-rated ingredients in Novel and Emerging Ingredients.
Trans-Resveratrol
62/100Trans-isomer of resveratrol; activates SIRT1, modulates AMPK, and provides antioxidant defence; rapidly metabolised to sulfate/glucuronide conjugates.
Urolithin A
52/100A gut-derived dibenzopyranone metabolite of ellagitannins that activates mitophagy (selective autophagy of damaged mitochondria) via PINK1/Parkin and AMPK/ULK1 signaling pathways.
Nicotinamide Mononucleotide
50/100A nucleotide intermediate in the NAD+ salvage pathway that is converted to NAD+ by nicotinamide mononucleotide adenylyltransferase (NMNAT) enzymes, restoring cellular NAD+ pools critical for redox metabolism and epigenetic regulation.
Research Overview
Limited EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/nmn
SuppIndex. (2026). NMN: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/nmn
Based on 1 indexed studies · Evidence level: Limited.
Goal Ratings
Stack Compatibility
Pair with TMG (methyl donor support), resveratrol (sirtuin synergy), pterostilbene.
Related evidence
Compare NMN with other researched ingredients.
- CoQ10— Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles …
- Urolithin A— A gut-derived dibenzopyranone metabolite of ellagitannins th…
Last reviewed Jun 2026
